Ignite Creation Date:
2024-05-06 @ 10:15 AM
Last Modification Date:
2024-10-26 @ 12:27 PM
Study NCT ID:
NCT03200808
Status:
COMPLETED
Last Update Posted:
2022-11-14
First Post:
2017-06-25
Brief Title:
Methylene Blue Injection for Nonneoplastic Epithelial Disorders of Vulva
Sponsor:
Maternal and Child Health Hospital of Hubei Province
Organization:
Maternal and Child Health Hospital of Hubei Province
Study Overview
Official Title:
Evaluation of the Efficacy of Mixed Methylene Blue Compound Injection for the Treatment of Nonneoplastic Epithelial Disorders of Vulva
Status:
COMPLETED
Status Verified Date:
2022-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NNEDsMB
Brief Summary:
The aim of this study is to demonstrate the safety and effectiveness of mixed methylene blue compound Injection for the treatment of nonneoplastic epithelial disordersNNEDS of vulva
NNEDS of skin and mucosa of vulva refer to a group of chronic diseases including squamous hyperplasia and lichen sclerosus which mainly cause vulvar itching and hypopigmentation Usually the itching is severe may influence social activities and sleep In addition NNEDS cause scarring of the vulva which may cause significant sexual dysfunction or pain The reasons for NNEDs are not clear and the methods of treatment are diverse The current treatments are primarily local drug eg steroid calcineurin inhibitors immunosuppressive agents surgical treatments laser or photodynamic therapy and the gold standard treatment for lichen sclerosus is potent steroids creams However all the treatments are not good enough and the diseases often recur and severely affect womens quality of life So the investigators reviewed plenty of literatures and found some authors used single intradermal 1 methylene blue injection for intractable idiopathic pruritus ani and the effect was good As a preliminary experiment the investigators used intradermal mixed methylene blue compound injection for a NNEDs patient in the year of 2012 the itching of the patient stopped immediately and the color of the vulva recovered 6 months later The patient keeps healthy till now And from then on the investigators designed this study and to verify the effect and complications of intradermal mixed methylene blue compound injection for the treatment of NNEDS So far there is no similar study reported internationally
NNEDS of skin and mucosa of vulva refer to a group of chronic diseases including squamous hyperplasia and lichen sclerosus which mainly cause vulvar itching and hypopigmentation Usually the itching is severe may influence social activities and sleep In addition NNEDS cause scarring of the vulva which may cause significant sexual dysfunction or pain The reasons for NNEDs are not clear and the methods of treatment are diverse The current treatments are primarily local drug eg steroid calcineurin inhibitors immunosuppressive agents surgical treatments laser or photodynamic therapy and the gold standard treatment for lichen sclerosus is potent steroids creams However all the treatments are not good enough and the diseases often recur and severely affect womens quality of life So the investigators reviewed plenty of literatures and found some authors used single intradermal 1 methylene blue injection for intractable idiopathic pruritus ani and the effect was good As a preliminary experiment the investigators used intradermal mixed methylene blue compound injection for a NNEDs patient in the year of 2012 the itching of the patient stopped immediately and the color of the vulva recovered 6 months later The patient keeps healthy till now And from then on the investigators designed this study and to verify the effect and complications of intradermal mixed methylene blue compound injection for the treatment of NNEDS So far there is no similar study reported internationally
Detailed Description:
Methylene blue compound injection are mixed by Methylene Blue injection Dexamethasone powder-injection Ropivacaine injection and Normal saline injection Each individual component can help in a very wide range of medical conditions without serious side effects
In this studythe investigators used methylene blue compound injection intradermally to treat NNEDs patients Patients with a diagnosis of biopsy proven NNEDs from Maternal and Child Health Hospital of Hubei Province China between October 2013 to October 2016 were recruited Every patient received intradermal mixed methylene blue compound injection twice All patients were observed during the hospitalization at the first injection and two weeks later they received the second injection at the outpatient department Ages itching scores percentage of hypopigmented skin and recurrences were recorded through inquiry and physical examination before and after treatment Side effects such as edema fever and vulva pain were also recorded All women were followed up 1 3 6 12 months after treatment which included inquiry and physical examination
In this studythe investigators used methylene blue compound injection intradermally to treat NNEDs patients Patients with a diagnosis of biopsy proven NNEDs from Maternal and Child Health Hospital of Hubei Province China between October 2013 to October 2016 were recruited Every patient received intradermal mixed methylene blue compound injection twice All patients were observed during the hospitalization at the first injection and two weeks later they received the second injection at the outpatient department Ages itching scores percentage of hypopigmented skin and recurrences were recorded through inquiry and physical examination before and after treatment Side effects such as edema fever and vulva pain were also recorded All women were followed up 1 3 6 12 months after treatment which included inquiry and physical examination
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None